Directory Menu Information

How and Why to Replace Single or Multiple Teeth Category:   Avaya IP Telephones - 4620, 5600 & 9600 - Product Comparson Category:   Eyelid Surgery: Preparing for Recovery Category:   Paleo Diet Snack Ideas - The 5-Minute Recipe Guide for 2 Astonis... Category:   Say NO To Animal Testing Category:   The Nokia C6 White features an easy to use email client Category:   Chicago kitchen remodeling- Useful Tips Category:   Medicare Supplemental Insurance Comparison - Make a Wise Choice Category:   How to Make Paleo Cookies - The Hidden Art of Making Mouth-Water... Category:   Get a Medicare Supplement Quote from Every Major Insurance Compa... Category:   Compare Medicare Supplements and Save Money! Category:   Fishing Bivvies - Three Good Reasons You Should Have A High Qual... Category:   Heaven Hill Category:   Self Improvement-Be The Best You Can Be With This Simple But Eff... Category:   Is DTS Therapy Better Than Chiropractic Care Category:   Balloon Columns At Your Special Event Category:   The Nokia C6 White has up to 16 gigabytes of storage memory Category:   Paleo Diet Recipes for Breakfast - Try This Easy and Tasty Speci... Category:   CCBN drive LCD and plasma TV's alternative contest - LCD, pl... Category:   Facebook fanpage for business Category:   Keep These Tips In Mind Before You Hire A Moving Company Category:   How to Quickly Advance Your Spanish and Impress Friends With Roc... Category:   The Nokia C6 White features a 3.2 inch resistive touch screen di... Category:   Want to Buy Cheap Extender?: A Vimax Extender Review Category:   Shopping for Successful Weight-Loss: Five Top Tips Category:   The Power Of Remote Management Computer Software To Make Work Ea... Category:   Using the Internet to Lower Costs Category:   How to Buy Short Sales and Profit From Them Category:   Things to Consider When Choosing a Unique Masquerade Prom Mask Category:   Starting that New Existence Category:   When an Ergonomic chair is not Solving Your Back Pain Look no Fu... Category:   3D TV manufacturers will dominate the next six Category:   Paleo Cookie Recipe - How to Bake Some Extremely Yummy Paleo Die... Category:   Todays Fashion Trend: Cubic Zirconia Bracelets Category:   How to Review a Doctor Category:   The Sony Ericsson X10 White offering a Mediascape feature which ... Category:   Getting Past Fear of Failure and Growing a Successful Business Category:   Soft Category:   Advantages of Dental Implants Category:   Appliance stores do not deserted during the Olympic Games Category:   Small Business Opportunity - How To Sell Without Being Pushy Category:   Taobao 2009 sales of footwear products in the Boots Women Nearly... Category:   Womens Swimwear That Makes You Look Slimmer: Miraclesuit Category:   The Sony Ericsson Zylo Silver with autorotate capabilities with ... Category:   How Online PR Can Help Your Search Engine Optimization Category:   learn muay tai Category:   Organization Ideas for Small Spaces Category:   Garage Door Materials: Pros and Cons Category:   Where Should I Get My Kids' Team Apparel Printed? Category:   Socialising again after a break up Category:   Professional Pay per Player offshore Services Category:   The Sony Ericsson Zylo Silver provides clips on YouTube with its... Category:   Tips to remain safe on a blind date Category:   So Much Hostility Category:   Festo (China) Co., Ltd. Wang Xiongyao Interview Category:   TM to Nance for 7 provinces Gree "double bid" - Shangh... Category:   Oaks Sales commandos rushed to help the national sales channel d... Category:   Native Remedies Promo Codes for All-Natural Treatments at the Lo... Category:   Expert online career counseling Category:   Benefits of Using Vitamin E for Skincare Category:   High Risk of Occupational Disabilities in Construction Industry Category:   SEO Services for small and medium businesses Category:   Problems Getting Pregnant? Some Quick Practical Ideas Category:   A Review Of The 37 Inch Sony KDL37EX503 Category:   Career transition coaching tests Category:   Optional air conditioning three steps Category:   Starscapes Home Business Opportunity Category:   Grown Ups Reunites Friends Category:   Latest 2010 collection of Breitling Replica Watches on AAAwatchr... Category:   A Comedy Film For Entire Family Category:   "My Online Business Strategy" - The Stuff You Need and Don't Get... Category:   Getting Ready for the Winter Snow Category:   Relaxation Techniques For Anxiety: How To Cope With Stressful Mo... Category:   New collection Breitling Replica Watches would be available at s... Category:   effectiveness of a career transition coach Category:

History of Acomplia during 2007 Sponsored Links History of Acomplia during 2007 History is a strange beast. By John Scott Category: 0 Submit your Articles Here! History is a strange beast. You can only see it when you turn and look back. The closer it is to you, the less easy it is to see. The difficulty with writing about acomplia is that you must always start somewhere. Wherever you pick in time, the real question is how far back to look. What have we taken for granted? What gaps have we left? So in this article, we catch up with the past. Just to make sure that we have everyone on the same virtual page. Acomplia (generic name rimonabant) has been an authorised medication in the EU since June 2006 for use in adult patients where the BMI exceeds 30 or the BMI exceeds 27 with associated risk factors such as diabetes. In all cases, it can only be prescribed in conjunction with a hypocaloric diet and physical exercise. 2007 was quite a good year. In March, the French government announced that acomplia was the first selective cannabinoid-1 receptor antagonist to be reimbursable by Social Security. Patients with prescriptions are entitled to recover 35% of the cost. The fact that no other medication has been approved for the subsidised treatment of obesity, gives acomplia a big market advantage in France. In April, the Swiss government followed suit, placing acomplia on the mandatory reimbursement list both for the treatment of patients with type 2 diabetes with a BMI of 28 or more, and for the treatment of any patient with a BMI greater than 35. But acceptance was not limited to Europe. April also saw an announcement from the Brazilian government that acomplia can be marketed to patients with a BMI over 30 or greater than 27 where there are risk factors present. In July, the European Medicines Agency (EMEA) modified its blanket approval for acomplia. It formally accepted evidence that there may be psychiatric side effects and so issued a directive that acomplia should not be prescribed to patients who have been diagnosed with major depression or who are already receiving antidepressants. In one sense, there was nothing new about this because the risk was identified when approval was first given in June 2006. But the EMEA’s Committee for Medicinal Products for Human Use (CHMP) changed the level of warning. The CHMP holds a general brief for monitoring the safety of medicines licensed for use in the EU. In June, it therefore requested Sanofi-Aventis, the French manufacturer, to submit all the available data it had in its possession on these side effects. In July, it concluded that the benefits of using acomplia continued to outweigh the possible disadvantages except in the cases where a patient was more seriously depressed. Thus, the warning now directs doctors either not to prescribe acomplia where a patient has been diagnosed as severely depressed, or to discontinue the use of acomplia if a patient subsequently becomes depressed. By publicising its findings, the CHMP was also taking steps to alert patients and their carers of the potential risk of using acomplia in relation to depression. In November, the European Commission accepted EMEA’s positive impression of acomplia, reacting favourably to the results of the SERENADE study (Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients), in which newly diagnosed type 2 diabetic patients showed significantly improved glycemic control and a reduction in cardio-metabolic risk factors. It is important to recognise that SERENADE is part of a more extensive Phase IIIb clinical trial program being carried out round the world. At present, there are more than 25,000 participants in eight further studies to study the effect of acomplia in the treatment of type 2 diabetes. These results are expected during the next two years. History of Acom 0 Subcategories Arts & Humanities > Art History > Business & Economy > History > Computers & Internet > History > Computers & Internet > Software > Computers & Internet > Year 2000 Problem > Entertainment > History > News & Media > History > News & Media > Media History > Science > History > Social Science > History > History of Acom 0 Articles